Pulmonary thromboembolic disease associated with COVID-19 infection: a comparison between geriatric and non-geriatric

T L Tan1, N E Illa2, S Y Ting3

  • 1Hospital Tengku Ampuan Rahimah, Internal Medicine Department, Selangor, Malaysia. tanthailun@gmail.com.

Insights

Elderly patients with Coronavirus Disease 2019 (COVID-19) and pulmonary thromboembolic disease face higher mortality risks. This study found older adults had more severe disease and worse outcomes despite earlier presentation.

Area of Science:

  • Medicine
  • Gerontology
  • Radiology

Background:

  • Coronavirus Disease 2019 (COVID-19) infection is increasing among the elderly.
  • Pulmonary thromboembolic (PTE) disease is a known complication of COVID-19.
  • Understanding differences in COVID-19 associated PTE between geriatric and non-geriatric patients is crucial.

Purpose of the Study:

  • To compare clinical and computed tomographical (CT) features of PTE in COVID-19 patients.
  • To explore the 60-day mortality rate in geriatric versus non-geriatric COVID-19 patients with PTE.
  • To identify risk factors and outcomes associated with PTE in elderly COVID-19 patients.

Main Methods:

  • Retrospective cross-sectional study.
  • Inclusion of patients with concomitant COVID-19 and PTE disease admitted in April-May 2021.
  • Analysis of demographic, clinical, laboratory, and CT pulmonary angiography (CTPA) data.

Main Results:

  • Higher prevalence of hypertension, diabetes, and dyslipidaemia in the geriatric cohort.
  • Geriatric patients had lower lymphocyte and albumin levels, and more severe disease despite earlier presentation.
  • Pulmonary thrombosis was predominantly in segmental/subsegmental arteries in both groups, with significantly higher in-hospital mortality in the elderly.

Conclusions:

  • Elderly patients with COVID-19 and PTE exhibit a higher mortality rate and poorer survival probability.
  • Typical COVID-19 symptoms may be masked in the elderly, potentially delaying diagnosis and increasing adverse outcomes.
  • Prompt recognition and management of PTE in geriatric COVID-19 patients are essential to improve outcomes.
Abstract

Related Concept Videos

Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
10
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
15
Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
17
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
368
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
287
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
287